Abstract 1985 Cytokines in Disease and Therapy Poster Symposium, Monday, 5/3
D+HUS, the most common cause of acute renal failure in childhood, is usually preceded by infection with Shiga toxin producing strains of E. coli. bFGF is an 18-kDa heparin-binding angiogenic peptide that is released by damaged endothelial and renal tubular epithelial cells. Because of the diffuse vascular injury in D+HUS, we determined whether there were changes in the plasma concentration and urinary excretion of bFGF during the acute and convalescent phases of the disease.
The first 19 consecutive patients (5 M: 14 F, mean age 5.5 yr), who were enrolled in the NIH-sponsored multicenter clinical trial of SYNSORB Pk in D+HUS, were included in this study. Assignment of patients to the SYNSORB Pk or placebo treatment groups was blinded. Serial plasma and urine samples were collected during the hospital course and a 60 day follow-up period after discharge. Control specimens were also collected from 5 healthy children attending Renal Clinic bFGF levels were measured using a commercially available ELISA kit. Urinary bFGF excretion was confirmed by Western analysis. Results (mean±SEM) were analyzed using a non-parametric ANOVA.
In the patients with D+HUS, plasma and urinary bFGF values were averaged for the initial 5 hospital days and the first 60 days after discharge. Compared to controls, the mean plasma bFGF concentration (pg/ml) was elevated in D+HUS patients, 13.7±4.0, acute phase, and 17.5±6.4, recovery period, versus 2.6±0.9, controls, P<0.001. Urinary bFGF excretion, corrected for creatinine, was also markedly elevated during the acute phase, 26.0±6.2 versus 3.9±1.5 in controls, P<0.001. However, urinary bFGF excretion declined to normal levels during the recovery period, 4.8±1.7.
We conclude that there is a significant increase in bFGF release during the acute phase of D+HUS due to widespread endothelial and renal tubular injury following systemic absorption of Shiga toxin. We speculate that the persistently elevated plasma bFGF concentration during the recovery period after D+HUS indicates involvement of the peptide in vascular regeneration while normalization of urinary bFGF excretion may be related to completion of renal tubular healing.
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Ray, P., Christen, E., Trachtman, H. et al. Basic Fibroblast Growth Factor (bFGF) in Diarrheal-Associated Hemolytic Uremic Syndrome (D+HUS). Pediatr Res 45, 336 (1999). https://doi.org/10.1203/00006450-199904020-02001
Issue Date:
DOI: https://doi.org/10.1203/00006450-199904020-02001